You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LRMR Buy Disclosure
Hamilton Thomas Edward · SEC Form 4 · Filed Jul 8, 2026
Buy
Calculated transaction value
$166.89K
Hamilton Thomas Edward Director
LRMR
Larimar Therapeutics
LRMR
Transaction date
Jul 6, 2026
Public filing date
Jul 8, 2026
Filing lag
Filed 2 days later
LRMR daily price context
Close on/before transaction
$3.29
Jul 6, 2026
First close after public filing
$4.13
Jul 9, 2026
30-day return after filing
+0.73%
Through Aug 7, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 50,000 shares @ $3.34
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001193125-26-298523
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$166.89K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Larimar Therapeutics, Inc. LRMR Current | Buy | Jul 6, 2026 | $166.89K |